Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,668 USD | -0,30% | -14,77% | -26,79% |
13/03 | Transcript : Gossamer Bio, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 07:30 AM | |
12/03 | Gossamer Bio kondigt benoeming in Raad van Bestuur aan | CI |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 151 mln. 141 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -180 mln. -168 mln. | Nettowinst (verlies) 2025 * | -196 mln. -183 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 13,32 mln. 12,46 mln. | Nettoliquiditeiten 2025 * | 23,83 mln. 22,29 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-0,9
x | K/w-verhouding 2025 * |
-0,95
x | Werknemers | 135 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,76% |
Recentste transcriptie over Gossamer Bio, Inc.
1 dag | -0,30% | ||
1 week | -14,77% | ||
Lopende maand | -43,39% | ||
1 maand | -42,91% | ||
3 maanden | -16,51% | ||
6 maanden | +36,33% | ||
Lopend jaar | -26,79% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 25-10-15 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 07-05-18 |
Chief Tech/Sci/R&D Officer | - | 03-10-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 25-10-15 |
Thomas Daniel
BRD | Director/Board Member | 69 | 01-01-18 |
Skye Drynan
BRD | Director/Board Member | - | 11/03 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.08% | 0 M€ | 0,00% | - | |
0.02% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,668 | -0,30% | 2 084 401 |
25-04-24 | 0,67 | -5,41% | 2 484 614 |
24-04-24 | 0,7083 | -3,97% | 798 638 |
23-04-24 | 0,7376 | -0,73% | 1 208 885 |
22-04-24 | 0,743 | -5,21% | 1 300 670 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-26,79% | 151 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |